<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">119061</article-id><article-id pub-id-type="doi">10.26442/00403660.2024.01.202574</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The effect of taking antibacterial therapy on the outpatient stage and outcomes of community-acquired pneumonia in Tomsk hospitals</article-title><trans-title-group xml:lang="ru"><trans-title>Влияние приема антибактериальных препаратов на амбулаторном этапе на течение и исходы внебольничной пневмонии в стационарах г. Томска</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8422-8349</contrib-id><name-alternatives><name xml:lang="en"><surname>Vinokurova</surname><given-names>Daria A.</given-names></name><name xml:lang="ru"><surname>Винокурова</surname><given-names>Дарья Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>зав. факультетской терапевтической клиникой</p></bio><email>elena-starovoytova@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0088-9204</contrib-id><name-alternatives><name xml:lang="en"><surname>Kulikov</surname><given-names>Evgeny S.</given-names></name><name xml:lang="ru"><surname>Куликов</surname><given-names>Евгений Сергеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>доктор медицинских наук, ректор</p></bio><email>evgeny.s.kulikov@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0098-1403</contrib-id><name-alternatives><name xml:lang="en"><surname>Kobyakova</surname><given-names>Olga S.</given-names></name><name xml:lang="ru"><surname>Кобякова</surname><given-names>Ольга Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>доктор медицинских наук, профессор, директор</p></bio><email>o.s.kobyakova@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4281-1157</contrib-id><name-alternatives><name xml:lang="en"><surname>Starovoytova</surname><given-names>Elena A.</given-names></name><name xml:lang="ru"><surname>Старовойтова</surname><given-names>Елена Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Head of the Department of General Medical Practice and Outpatient Therapy</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, доцент, заведующий кафедрой общей врачебной практики и поликлинической терапии</p></bio><email>elena-starovoytova@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4449-4810</contrib-id><name-alternatives><name xml:lang="en"><surname>Deev</surname><given-names>Ivan A.</given-names></name><name xml:lang="ru"><surname>Деев</surname><given-names>Иван Анатольевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>доктор медицинских наук, профессор, зам. директора по организации здравоохранения</p></bio><email>deevia@mednet.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6655-3300</contrib-id><name-alternatives><name xml:lang="en"><surname>Fedosenko</surname><given-names>Sergey V.</given-names></name><name xml:lang="ru"><surname>Федосенко</surname><given-names>Сергей Вячеславович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>доктор медицинских наук, доцент, профессор кафедры общей врачебной практики и поликлинической терапии</p></bio><email>sergey.fedosenko@icloud.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5780-6660</contrib-id><name-alternatives><name xml:lang="en"><surname>Chernogoryuk</surname><given-names>Georgy E.</given-names></name><name xml:lang="ru"><surname>Черногорюк</surname><given-names>Георгий Эдинович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>доктор медицинских наук, профессор кафедры госпитальной терапии с курсом реабилитации, физиотерапии и спортивной медицины</p></bio><email>chernogoryuk@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0553-4410</contrib-id><name-alternatives><name xml:lang="en"><surname>Chernysheva</surname><given-names>Ekaterina A.</given-names></name><name xml:lang="ru"><surname>Чернышева</surname><given-names>Екатерина Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>врач</p></bio><email>cherniisheva69@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3619-6095</contrib-id><name-alternatives><name xml:lang="en"><surname>Yarovoy</surname><given-names>Nikolay D.</given-names></name><name xml:lang="ru"><surname>Яровой</surname><given-names>Николай Дмитриевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>врач</p></bio><email>koly-yarovoy@yandex.ru</email><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Siberian State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Сибирский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Russian Research Institute of Health</institution></aff><aff><institution xml:lang="ru">ФГБУ «Центральный научно-исследовательский институт организации и информатизации здравоохранения» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Medical and Sanitary Unit №2</institution></aff><aff><institution xml:lang="ru">ОГБУЗ «Медико-санитарная часть №2»</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Tomsk Regional Oncology Center</institution></aff><aff><institution xml:lang="ru">ОГАУЗ «Томский областной онкологический диспансер»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-01-25" publication-format="electronic"><day>25</day><month>01</month><year>2024</year></pub-date><volume>96</volume><issue>1</issue><issue-title xml:lang="en">Outpatient care issues and organization of medical care</issue-title><issue-title xml:lang="ru">Поликлинические проблемы и организация медицинской помощи</issue-title><fpage>11</fpage><lpage>16</lpage><history><date date-type="received" iso-8601-date="2022-12-18"><day>18</day><month>12</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/119061">https://ter-arkhiv.ru/0040-3660/article/view/119061</self-uri><abstract xml:lang="en"><p><bold>Background. </bold>Community-acquired pneumonia (CAP) remains one of the most common diseases requiring urgent hospitalization, with a significant part of patients already receiving antibiotics before admission to the hospital.</p> <p><bold>Aim. </bold>To assess the relationship between outpatient antibacterial therapy and in-hospital mortality and the severity of the CAP.</p> <p><bold>Materials and methods. </bold>The retrospective study included the data of adult patients with CAP who were hospitalized in Tomsk from January 1 to December 31, 2017.</p> <p><bold>Results. </bold>Among 1412 patients, 22.2% received antibiotics before admission to the hospital, the proportion of deaths in this group was significantly lower – 3.8% compared with 10.6% among patients without antibiotic therapy (p&lt;0.001). Subjects who received antibiotics on outpatient basis were less likely to require being in the intensive care unit and administering vasopressors, in contrast to patients without prior antibiotic therapy: 5.1 and 10.6% (p=0.003); 7.1 and 4.7% (p=0.018) respectively. In patients with severe CAP on a scale IDSA/ATS, only 11.8% of cases were detected with antibiotics before hospitalization, while in mild CAP the frequency of administration was 16.6% (p&lt;0.001).</p> <p><bold>Conclusion. </bold>Ambulatory antibacterial therapy had a positive effect on the subsequent course and outcomes of CAP in a hospital setting. Patients had a predominantly mild course of the disease, needing for vasopressors, and being in the intensive care unit, but was not consistent with the need for invasive mechanical ventilation.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование. </bold>Внебольничная пневмония (ВП) остается одной из наиболее распространенных бактериальных инфекций, требующих госпитализации, при этом весомая доля больных уже получают антибиотики до поступления в стационар.</p> <p><bold>Цель. </bold>Оценить связь между амбулаторным приемом антибактериальных препаратов и последующей внутрибольничной смертностью и тяжестью течения ВП.</p> <p><bold>Материалы и методы. </bold>В ретроспективное исследование включены данные взрослых пациентов с ВП, госпитализированных в стационары г. Томска в период с 1 января по 31 декабря 2017 г.</p> <p><bold>Результаты. </bold>Среди 1412 больных 22,2% получали антибиотики до поступления в стационар, процент умерших пациентов в этой группе оказался достоверно ниже и составил 3,8% против 10,6% умерших, не получавших антибиотикотерапии (p&lt;0,001). Пациенты, получившие антимикробные препараты амбулаторно, реже требовали нахождения в отделении реанимации и введения вазопрессоров в отличие от больных, которые не получали антибиотики на догоспитальном этапе: 5,1 и 10,6% (p=0,003); 7,1 и 4,7% (p=0,018) соответственно. При делении пациентов на степени тяжести согласно критериям IDSA/ATS среди больных с тяжелым течением только 11,8% принимали антибиотики до госпитализации, тогда как у нетяжелых частота приема составила 16,6% (p&lt;0,001).</p> <p><bold>Заключение. </bold>Амбулаторный прием антибактериальных препаратов положительно влиял на дальнейшее течение и исходы ВП в условиях стационара, уменьшал потребность в вазопрессорах и нахождении в отделении реанимации, но не связан с необходимостью в инвазивной искусственной вентиляции легких.</p></trans-abstract><kwd-group xml:lang="en"><kwd>community-acquired pneumonia</kwd><kwd>antibiotics</kwd><kwd>pneumonia</kwd><kwd>severity</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>внебольничная пневмония</kwd><kwd>антибиотики</kwd><kwd>пневмония</kwd><kwd>тяжесть</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>‏ 10 ведущих причин смерти в мире. Всемирная организация здравоохранения. Режим доступа: https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causes-of-death. Ссылка активна на 01.12.2022 [The top 10 causes of death. World health Organization. Available at: https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causes-of-deathAccessed: 01.12.2022 [(in Russian)].</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Инфекционная заболеваемость в Российской Федерации за январь – декабрь 2018 г. Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. Режим доступа: https://rospotrebnadzor.ru/activities/statistical-materials/statictic_details.php?ELEMENT_ID=11277. Ссылка активна на 15.01.2024 [Infectious morbidity in the Russian Federation for January – December 2018 Federal Service for Supervision of Consumer Rights Protection and Human Well-Being. Available at: https://rospotrebnadzor.ru/activities/statistical-materials/statictic_details.php?ELEMENT_ID=11277. Accessed: 15.01.2024 (in Russian)].</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Bjarnason A, Westin J, Lindh M, et al. Incidence, Etiology, and Outcomes of Community-Acquired Pneumonia: A Population-Based Study. Open Forum Infect Dis. 2018;5(2):ofy010. DOI:10.1093/ofid/ofy010</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Van de Garde EM, Souverein PC, Van den Bosch JM, et al. Prior outpatient antibacterial therapy as prognostic factor for mortality in hospitalized pneumonia patients. Respir Med. 2006;100(8):1342-8. DOI:10.1016/j.rmed.2005.11.024</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Chakrabarti B, Wootton D, Lane S, et al. The association between pre-hospital antibiotic therapy and subsequent in-hospital mortality in adults presenting with community-acquired pneumonia: an observational study. Pneumonia (Nathan). 2018;10:2. DOI:10.1186/s41479-018-0047-4</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Amaro R, Sellarés J, Polverino E, et al. Antibiotic therapy prior to hospital admission is associated with reduced septic shock and need for mechanical ventilation in patients with community-acquired pneumonia. J Infect. 2017;74(5):442-9. DOI:10.1016/j.jinf.2017.01.009</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377-82. DOI:10.1136/thorax.58.5.377</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44 Suppl. 2:S27-72. DOI:10.1086/511159</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Simonetti AF, Garcia-Vidal C, Viasus D, et al. Declining mortality among hospitalized patients with community-acquired pneumonia. Clin Microbiol Infect. 2016;22(6):567.e1-5677. DOI:10.1016/j.cmi.2016.03.015</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Kolditz M, Bauer TT, König T, et al. 3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors. Eur Respir J. 2016;47(5):1572-4. DOI:10.1183/13993003.00113-2016</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Simonetti AF, Viasus D, Garcia-Vidal C, et al. Impact of pre-hospital antibiotic use on community-acquired pneumonia. Clin Microbiol Infect. 2014;20(9):O531-7. DOI:10.1111/1469-0691.12524</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Havers FP, Hicks LA, Chung JR, et al. Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons. JAMA Netw Open. 2018;1(2):e180243. DOI:10.1001/jamanetworkopen.2018.0243</mixed-citation></ref></ref-list></back></article>
